Efficacy and safety of tripterygium wilfordii Hook F plus TNF inhibitor for active rheumatoid arthritis: A multicentre, randomized, double-blind, triple-dummy controlled trial.

[1]  Xuan Zhang,et al.  A high-fiber diet synergizes with Prevotella copri and exacerbates rheumatoid arthritis , 2022, Cellular & Molecular Immunology.

[2]  Wei Gao,et al.  Triptolide: pharmacological spectrum, biosynthesis, chemical synthesis and derivatives , 2021, Theranostics.

[3]  H. Matsuno,et al.  Comparison of the efficacy and safety of LBAL, a candidate adalimumab biosimilar, and adalimumab reference product in patients with active rheumatoid arthritis inadequately responding to methotrexate: a 52-week phase III randomised study. , 2020, Clinical and experimental rheumatology.

[4]  Zhuoli Zhang,et al.  Efficacy of methotrexate and etanercept biosimilar rhTNFR:Fc in Chinese patients with active rheumatoid arthritis: A controlled, randomized and multicenter study , 2020, Scientific Reports.

[5]  Tsutomu Takeuchi,et al.  EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update , 2020, Annals of the Rheumatic Diseases.

[6]  J. Smolen,et al.  Diagnosis and Management of Rheumatoid Arthritis: A Review , 2018, JAMA.

[7]  P. Lipsky,et al.  Comparison of the impact of Tripterygium wilfordii Hook F and Methotrexate treatment on radiological progression in active rheumatoid arthritis: 2-year follow up of a randomized, non-blinded, controlled study , 2018, Arthritis Research & Therapy.

[8]  Q. Wang,et al.  Chinese registry of rheumatoid arthritis (CREDIT): I. Introduction and prevalence of remission in Chinese patients with rheumatoid arthritis. , 2018, Clinical and experimental rheumatology.

[9]  J. Zhao,et al.  A Mechanistic Overview of Triptolide and Celastrol, Natural Products from Tripterygium wilfordii Hook F , 2018, Front. Pharmacol..

[10]  W. Dixon,et al.  Spectrum of lymphomas across different drug treatment groups in rheumatoid arthritis: a European registries collaborative project , 2017, Annals of the rheumatic diseases.

[11]  R. Moots,et al.  Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial , 2017, The Lancet.

[12]  I. McInnes,et al.  Rheumatoid arthritis , 2016, The Lancet.

[13]  P. Santos-Moreno,et al.  Direct Comparative Effectiveness Among 3 Anti–Tumor Necrosis Factor Biologics in a Real-Life Cohort of Patients With Rheumatoid Arthritis , 2016, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

[14]  Huijue Jia,et al.  The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment , 2015, Nature Medicine.

[15]  Lifei Peng,et al.  Modulation of IL-37 expression by triptolide and triptonide in THP-1 cells , 2014, Cellular and Molecular Immunology.

[16]  P. Lipsky,et al.  Comparison of Tripterygium wilfordii Hook F with methotrexate in the treatment of active rheumatoid arthritis (TRIFRA): a randomised, controlled clinical trial , 2014, Annals of the rheumatic diseases.

[17]  Z. Yin,et al.  [Etanercept combined with Tripterygium wilfordii polyglycoside for treatment of rheumatoid arthritis in the elderly: a clinical study]. , 2014, Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine.

[18]  Yanqiong Zhang,et al.  Triptolide Prevents Bone Destruction in the Collagen-Induced Arthritis Model of Rheumatoid Arthritis by Targeting RANKL/RANK/OPG Signal Pathway , 2013, Evidence-based complementary and alternative medicine : eCAM.

[19]  Fengchun Zhang,et al.  The Safety and Effectiveness of a Chloroform/Methanol Extract of Tripterygium wilfordii Hook F (T2) Plus Methotrexate in Treating Rheumatoid Arthritis , 2010, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

[20]  P. Lipsky,et al.  Comparison of Tripterygium wilfordii Hook F Versus Sulfasalazine in the Treatment of Rheumatoid Arthritis , 2009, Annals of Internal Medicine.

[21]  Changyou Wu,et al.  Triptolide Inhibits the Differentiation of Th17 cells and Suppresses Collagen‐induced Arthritis , 2008, Scandinavian journal of immunology.

[22]  P. Lipsky,et al.  Effective therapy for nephritis in (NZB x NZW)F1 mice with triptolide and tripdiolide, the principal active components of the Chinese herbal remedy Tripterygium wilfordii Hook F. , 2008, Arthritis and rheumatism.

[23]  P. Lipsky,et al.  Triptolide, an active component of the Chinese herbal remedy Tripterygium wilfordii Hook F, inhibits production of nitric oxide by decreasing inducible nitric oxide synthase gene transcription. , 2004, Arthritis and rheumatism.

[24]  P. Lipsky,et al.  Benefit of an extract of Tripterygium Wilfordii Hook F in patients with rheumatoid arthritis: a double-blind, placebo-controlled study. , 2002, Arthritis and rheumatism.

[25]  P. Lipsky,et al.  A phase I study of ethyl acetate extract of the chinese antirheumatic herb Tripterygium wilfordii hook F in rheumatoid arthritis. , 2001, The Journal of rheumatology.

[26]  Richard W. Martin,et al.  A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. , 2000, The New England journal of medicine.

[27]  C. Bao,et al.  A comparison study of a recombinant tumor necrosis factor receptor:Fc fusion protein (rhTNFR:Fc) and methotrexate in treatment of patients with active rheumatoid arthritis in China , 2008, Rheumatology International.